Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-24 16:36 CEST (UTC+2h)
libaiyi
Junior

China,
2018-06-14 09:32

Posting: # 18904
Views: 296
 

 the difference between winnonlin and nonmem [Software]

Hi,

when I use data from offcial Phoenix support forum, I can't get the same results from winnonlin and nonmem. Is there any difference in algorithm in two softwares? Or does it exist some mistakes in code? :-D:-D:-D


Edit: Please don’t shout[Helmut]
Helmut
Hero
avatar
Homepage
Vienna, Austria,
2018-06-14 13:03

@ libaiyi
Posting: # 18907
Views: 231
 

 Nonlinear mixed effects models

Hi libaiyi,

» I can't get the same results from winnonlin and nonmem.

Well, we are dealing with nonlinear mixed effects models with all the bells and whistles. The software tries to find the optimum in an n+1 dimensional parameter-space. NONMEM and Phoenix/NLME employ maximum likelihood, whereas WinNonlin least squares. See this post for details and the presentation given at the PAGE meeting 2005 about comparing PopPK software in a blinded manner. Also interesting: Bauer et al.1, Colby and Bair2. The latter deals with Phoenix.

» Is there any difference in algorithm in two softwares?

Well, in both there are more than one. It would be very difficult to get exactly the same results even if you use the same algorithm, initial estimates, parameter constraints, convergence criteria, max. number of iterations, :blahblah:
We can only hope that an algo converges to the global – and not a local – optimum.
That’s the reason why in BE only NCA is acceptable.

» Or does it exist some mistakes in code?

Always possible (see this presentation). The software industry generally considers one defect / 2,000 lines of code ‘stable’. Oh dear! Package PowerTOST has currently ~10,200 LOC – I hope, we did better. Of course, higher standards are used in certain fields (see what I wrote about white-box validation in this post).


  1. Bauer RJ, Guzy S, Ng C. Survey of Population Analysis Methods and Software for Complex Pharmacokinetic and Pharmacodynamic Models with Examples. AAPS J. 2007;9(1):E60–83. doi:10.1208/aapsj0901007. [image] free resource.
  2. Colby E, Bair E. Cross-Validation for Nonlinear Mixed Effects Models. J Pharmacokinet Pharmacodyn. 2013;40(2):243–52. doi:10.1007/s10928-013-9313-5. [image] free resource. [image] supplementary material.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
18,425 posts in 3,913 threads, 1,176 registered users;
online 31 (0 registered, 31 guests [including 27 identified bots]).

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed